News
The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia (SFE SFUS) is organising the Seventh International Conference on the topic of:
"HEALTH ECONOMICS AND HEALTH TECHNOLOGY ASSESSMENT WHEN DIABETES IS EVERYWHERE",
The Conference will take place on March 20th, 2020 at the hotel Crowne Plaza, in Belgrade Serbia.
The Conference will represent a unique event in Serbia and the region, which will provide an opportunity for a proactive participation and an open debate between the participants on comprehensive health care solutions for the global challenge of diabetes. The program of the Conference will be soon available at the website: http://www.farmakoekonomija.org and http://www.farmacija.org/.
The aim of the Conference is to share international experience and solutions for the optimization of health care, in the face of the growing epidemic of type 2 diabetes.
The main panels of the Conference will include:
Contemporary evidence-based medicine: Clinical trials and Real-World Evidence
The burden of comorbidities for the health care resource utilisation
Patient management pathways
The role of digital health in optimizing patient care
Several preliminary topics will comprise:
Addressing clinical inertia in type 2 diabetes management
Practical implications of surveys and patient registries
Improvement of patient care with connected medical devices
How to get the best of meta-analysis
The role of data sharing
A guide to practice guidelines: evolving concepts in guidelines development
Clinical benefits of new glucose-lowering medications
The Conference program is intended for the audience of decision makers, health-care policy creators, managers in health care institutions, employees of pharmaceutical companies (in sectors of market access, pricing, health economics, regulation, marketing and sales), medical doctors, pharmacists and allied health-care professional employed in the public and private sectors.
Participants of the Conference will have the opportunity to broaden their knowledge on the heath economics and health technology assessment, as well as on clinical aspects of type 2 diabetes management, through interactive sessions and open exchange of opinion with prominent international and local experts.
The following speakers confirmed their participation at the Conference:
Iñaki Gutiérrez-Ibarluzea, HTAi President, Bilbao, Spain
Antony P. Martin, HCD Economist, Madrid, Spain
Marija Polovina, Department of Cardiology, Clinical Center of Serbia, University of Belgrade, Faculty of Medicine, Serbia
Mark Parker, ZEM Solutions, Belgrade, Serbia
Krzysztof Łanda MD, President at Meritum L.A, Former Deputy Minister of Health of the Republic of Poland 2015-2017
Wija Oortwijn, Radboud University Medical Centre, Department for Health Evidence & HTAi, Nijmegen, The Netherlands; HTAi Vice-President
Conference participants |
Registration fee |
SFUS members |
225 € |
Others |
275 € |
Undergraduate students |
100 € |
Meet the experts dinner |
50 € |
Executive Organizer: SMART TRAVEL PCO, Njegoševa 72 a, Beograd,
Phones: + 381 11 770 2184Fax: + 381 11 244 7524, E- mail address: smarttravelpco4@smarttravelpco4.rs Web address: www.smarttravelpco4.rs
Marketing offer to sponsors will soon be available.
EDUCATIONAL COURSE
DECISION MAKING IN PRACTICE
Dear colleagues,It is our greatpleasure to invite you to the Educational course with a topic “Decision making in practice” which will be held on 28th March 2019, in the Pharmaceutical Association of Serbia, BulevarvojvodeMisica Street 25, Belgrade.
Objective of the course:
The aim of this course is to enable health professionals in Serbia to understand the basic principles of health economic theory and practice, and better understand how the application of health economic techniques and methodologies can improve healthcare decision making throughout Serbia in these challenging times.For whom the course is intended for:
Educational course is intended for decision-makers, health policy makers, healthcare managers, pharmaceutical companies (in the sectors of market access, pricing, healthcare, regulation, marketing and sales, medical affairs), doctors and pharmacists working in the public and private sectors.PROGRAM
12:00 - 12:10 Registration12:10 - 12:20 Introduction to the Course and Participants
12:20 - 12:45 The Role of Health Economics and Health Technology Assessment in decision making Tanja Novakovic MSc Pharm,Pharmacoeoconomics Section President, ZEM Solutions ltd
12:45-13:05 Tools for Healthcare Decision Making Mark Parker MSc, ZEM Solutions ltd
13:05-13:30 Coffee networking break
13:30-16:00 Workshop “Decision making in practice” (example with CANCER DRUGS)
16:00-16:30 Discussion, Evaluation and Closing of the Course
Knowledge of English is necessary for the participation of this education.
COURSE INSTRUCTORS:
The course will be led by Tanja Novakovic and Mark Parker, directors of ZEM Solutions Ltd(http://zem-solutions.com).Tanja and Mark have international reputations in health economics and health technology assessment. They have a detailed knowledge of the practical evaluation of healthcare interventions across Europe and Serbia as well, that will enable participants to become familiar with health economic terminology and methodology within a real-world context and their application to enhance reimbursement and funding for medicines including cancer medicines.REGISTRATION
| Course participants | Registration fees (RSD) |
| SFUS members | 3000.00 |
| Others | 4000.00 |
| Undergraduate students | 2000.00 |
INFORMATION
Payment of the registration fee can be made to the business account of the Pharmaceutical Association of Serbia: 205-14830-24CONTACT INFORMATION
Telephone/Fax:+381 11 2648 385
+381 11 2648 386
e-mail: sfus@farmacija.org
We are pleased to inform that Pharmacoeconomics Section of the Pharmaceutical Association of Serbia (SFE SFUS) is participating at 7th Serbian Congress of Pharmacists with a Session which main topic is: “HEALTH CARE DECISION MAKING FROM THE PHARMACOECONOMIC PERSPECTIVE”, which will take place in Belgrade on Friday 12th October 2018, Crowne Plaza Hotel, Belgrade, Serbia. It is our great honour to announce that Wija Oortwijn will held Preliminarry lecture on “VALUE FRAMEWORKS AND DECISION MAKING AROUND THE GLOBE”. Wija is the scientific secretary of HTAi’s Global Policy Forum: for 2016-2017 (on value frameworks), for 2017-2018 (on horizon scanning) and for 2018-2019 (on real world evidence).
The full programme of the Session is available at the www.farmakoekonomija.org
We are looking forward to welcoming at Session of the SFE SFUS of the 7th Serbian Congress of Pharmacists!
Sincerely,President of the Pharmacoeconomics Section
Tanja Novakovic
Conclusions from the 6th Pharmacoeconomics Section International Conference
The Value in Innovation in Decision Making
Dear colleagues,Innovations drive increased spending in health care systems as new medicines tend to be priced higher than current standards. Financial stability, the main aim of the health system of CEE region, depends on two key challenges, which are how to best spend resources which are already in the system and the other challenge is should the health system have more or less money. To be relevant to decision making in the CEE region, HTA agencies must address these key challenges.
MEAs are one part of addressing financial stability of health systems in CEE region. But MEAs should be applied together with HTA, so they can start to address clinical and economic uncertainties and provide a transparent and timewise framework for deliberative decision-making. However, this is challenging at the moment with typically confidential arrangements between companies and payers, as well as a reluctance among companies to make decision making more transparent as seen for instance in Poland.
A lack of access to innovative health technologies is causing significant harm both in the region and globally, particularly in Serbia. However providing access to such technologies is politically and financially complex and challenging.
We look forward to welcoming you to our future Conferences.
With kind regards,MSc Tanja Novakovic
Pharmacoeconomics Section President
"THE VALUE OF INNOVATION IN DECISION MAKING"
The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia (SFE SFUS) is organising its Sixth International Conference with the topic:
"THE VALUE OF INNOVATION IN DECISION MAKING", which will take place in Belgrade on 2nd June 2017, hotel Metropol, Serbia
Conference program will be proactive and it will represent unique event in Serbia and region.
(http://www.farmakoekonomija.org and http://www.farmacija.org/).
Main topics of the Conference are:
Managed Entry Agreements (MEA)
Link between MEA and Health Technology Assessment (HTA)
Access to personalised medicines, orphan drugs and high cost medicines
Role of patient registries in Access to medicines
The public economics consequences of health and investments in healthcare
The Conference program is intended for decision makers, makers of health policy design managers in health care institutions, employees of pharmaceutical companies (in the sectors of market access, pricing, health economics, regulation, marketing and sales), doctors and pharmacists who work in the public and private sectors. Participants of the Conference will have the opportunity to obtain new knowledge from world and local experts and exchange their experience and opinions.
| Conference Participants | Registration fees | |
| till 25th March 2017 | From 25th March 2017 | |
| SFUS members | 225 € | 275 € |
| Others | 300 € | 350 € |
| Undergraduate students | 100 € | 150 € |
| Meet the experts dinner | 50 € | 50 € |
It is our great honour and pleasure to congratulate you on the jubilee of Pharmacoeconomics Section of the Pharmaceutical Association of Serbia, which marks 10 years of our section.
I wish you all continued success in our future work!
BB Soft informantor has published an interview where I discuss the challenges of health and pharmacoeconomics in the region, along with the development of the section, our activities and future plans.
With kind regards,MSc Tanja Novakovic
Pharmacoeconomics Section President